Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury

Blood

Volumn 111, Issue 8, 2008, Pages 4137-4144

  Werneck, Claudio C ^a   Vicente, Cristina P ^a   Weinberg, Justin S ^b   Shifren, Adrian ^b   Pierce, Richard A ^b   Broekelmann, Thomas J ^b   Tollefsen, Douglas M ^b   Mecham, Robert P ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRONECTIN; MICROFIBRIL ASSOCIATED GLYCOPROTEIN 1; SCLEROPROTEIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; CONTRACTILE PROTEIN; MICROFIBRILLAR PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CAROTID ARTERY INJURY; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS; ANIMAL; BLEEDING TIME; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD PRESSURE; C57BL MOUSE; CAROTID ARTERY; CATTLE; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; INJECTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SURFACE PLASMON RESONANCE; THROMBOCYTE;

ANIMALS; BLEEDING TIME; BLOOD COAGULATION; BLOOD PLATELETS; BLOOD PRESSURE; CAROTID ARTERIES; CATTLE; CONTRACTILE PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FIBRINOGEN; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS; MICE; MICE, INBRED C57BL; PLATELET FUNCTION TESTS; PROTEIN BINDING; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 43249125237     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-07-101733     Document Type: Article

References (30)

1. de Groot PG, Ottenhot-Rovers M, van Mourik JA, Sixma JJ. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. J Clin Invest. 1988;82:65-73.
2. Wagner DD, Urban-Pickering M, Marder VJ. Von Willebrand protein binds to extracellular matrices independently of collagen. Proc Natl Acad Sci U S A. 1984;81:471-475.
3. Gibson MA, Cleary EG. The immunohistochemical localization of microtibril-associated glycoprotein (MAGP) in elastic and non-elastic tissues. Immunol Cell Biol. 1987;65:345-356.
4. Gibson MA, Kumaratilake JS, Cleary EG. The protein components of the 12-nanometer microfibrils of elastic and non-elastic tissues. J Biol Chem. 1989;264:4590-4598.
5. Kielty CM, Sherratt MJ, Marson A, Baldock C. Fibrillin microfibrils. Adv Protein Chem. 2005;70:405-436.
6. Mecham RP, Madaras J, McDonald JA, Ryan U. Elastin production by cultured calf pulmonary artery endothelial cells. J Cell Physiol. 1983;116:282-288.
7. Weber E, Rossi A, Solito R, Agliano M, Sacchi G, Gerli R. The pattern of fibrillin deposition correlates with microfibril-associated glycoprotein 1 (MAGP-1) expression in cultured blood and lymphatic endothelial cells. Lymphology. 2004;37:116-126.
8. Davis EC. Smooth muscle cell to elastic lamina connections in the developing mouse arota: Role in aortic medial organization. Lab Invest. 1993;68:89-99.
9. Davis EC. Endothelial cell connecting filaments anchor endothelial cells to the subjacent elastic lamina in the developing aortic intima of the mouse. Cell Tiss Res. 1993;272:211-219.
10. Ross R, Bornstein P. The elastic fiber, I: the separation and partial characterization of its macromolecular components. J Cell Biol. 1969;40:366-381.
11. Birembaut P, Legrand YJ, Bariety J, et al. Histochemical and ultrastructural characterization of subendothelial glycoprotein microfibrils interacting with platelets. J Histochem Cytochem. 1982;30:75-80.
12. Legrand YJ, Fauvel-Lafeve F. Molecular mechanism of the interaction of subendothelial microfibrils with blood platelets. Nouv Rev Fr Hematol. 1992;34:17-25.
13. Fauvel-Lafeve F, Legrand YJ. Binding of plasma von Willebrand factor by arterial microfibrils. Thromb Haemost. 1990;64:145-149.
14. Trask BC, Broekelmann TJ, Mecham RP. Post-translational modifications of microfibril associated glycoprotein-1 (MAGP-1). Biochem. 2001;40:4372-4380.
15. Segade F, Trask BC, Broekelmann T, Pierce RA, Mecham RP. Identification of a matrix binding domain in MAGP1 and 2 and intracellular localization of alternative splice forms. J Biol Chem. 2002;277:11050-11057.
16. Brown-Augsburger P, Broekelmann T. Mecham L. et al. Microfibril- associated glycoprotein (MAGP) binds to the carboxy-terminal domain of tropoelastin and is a substrate fortransglutaminase. J Biol Chem. 1994;269:28443-28449.
17. Finnis ML, Gibson MA. Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen. J Biol Chem. 1997;272:22817-22823.
18. Trask BG, Trask TM, Broekelmann T, Mecham RP. The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Molec Biol Cell. 2000;11:1499-1507.
19. Reinboth B, Hanssen E, Cleary EG, Gibson MA. Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril- associated glycoprotein 1. J Biol Chem. 2002;277:3950-3957.
20. Miyamoto A, Lau R, Hein PW, Shipley JM, Wein-master G. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notchl extracellular domain dissociation and receptor activation. J Biol Chem. 2006;281:10089-10097.
21. Eitzman DT, Westrick RJ, Xu Z, Tyson J, Gins-burg D. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood. 2000;96:4212-4215.
22. Vicente CP, He L, Pavao MS, Tollefsen DM. Antithrombotic activity of dermatan sulfate in heparin cofactor ll-deficient mice. Blood. 2004;104:3965-3970.
23. Broze GJ Jr, Yin ZF, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost. 2001;85:747-748.
24. Cazenave JP, Ohlmann P, Cassel D, Eckly A, Hechler B, Gachet C. Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol. 2004;272:13-28.
25. Faury G, Pezet M, Knutsen RH, et al. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J Clin Invest. 2003;112:1419-1428.
26. Wagenseil JE, Nerurkar NL, Knutsen RH, Okamoto RJ, Li DY, Mecham RP. Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. Am J Physiol Heart Circ Physiol. 2005;289:H1209-H1217.
27. Werneck CC, Trask BC, Broekelmann TJ, et al. Identification of a major microfibril-associated glycoprotein-1-binding domain in fibrillin-2. J Biol Chem. 2004;279:23045-23051.
28. Fauvel F, Grant ME, Legrand YJ, et al. Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. Proc Natl Acad Sci U S A. 1983;80:551-554.
29. KyriakidesTR, Zhu YH, Smith LT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol. 1998;140:419-430.
30. Bonnefoy A, Daenens K, Feys HB, et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage byADAMTS13. Blood. 2006;107:955-964.